Stay updated with breaking news from Merck prevymis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Merck's efinopegdutide shows promise in nonalcoholic fatty liver disease pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
The FDA on Tuesday approved letermovir for the prevention of cytomegalovirus disease in high-risk adult kidney transplant recipients, Merck announced. ....